Ovelle Bio
Ovelle Bio is a US startup, founded in 2024. It has raised at least $7.0m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Ovelle Bio has raised at least $7.0m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
Related
Questions and answers
What does Ovelle Bio do?
Ovelle Bio is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Ovelle Bio raised?
At least $7.0m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Ovelle Bio based?
Ovelle Bio is registered in United States; its operating headquarters is not yet confirmed.
When was Ovelle Bio founded?
Ovelle Bio was founded in 2024.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.